Originally published In Press as doi:10.1074/jbc.M202395200 on September 24, 2002
J. Biol. Chem., Vol. 277, Issue 48, 46696-46705, November 29, 2002
Calreticulin Differentially Modulates Calcium Uptake and Release
in the Endoplasmic Reticulum and Mitochondria*
Serge
Arnaudeau
,
Maud
Frieden
,
Kimitoshi
Nakamura§,
Cyril
Castelbou
,
Marek
Michalak§¶, and
Nicolas
Demaurex
From the
Department of Physiology, University of
Geneva, 1211 Geneva 4, Switzerland and § Canadian
Institutes of Health Research Membrane Proteins Research Group and the
Department of Biochemistry, University of Alberta,
Edmonton, Alberta T6G 2H7, Canada
Received for publication, March 12, 2002, and in revised form, September 24, 2002
 |
ABSTRACT |
To study the role of calreticulin in
Ca2+ homeostasis and apoptosis, we generated cells
inducible for full-length or truncated calreticulin and measured
Ca2+ signals within the cytosol, the endoplasmic reticulum
(ER), and mitochondria with "cameleon" indicators. Induction
of calreticulin increased the free Ca2+ concentration
within the ER lumen, [Ca2+]ER, from 306 ± 31 to 595 ± 53 µM, and doubled the rate of ER refilling. [Ca2+]ER remained elevated in the
presence of thapsigargin, an inhibitor of SERCA-type Ca2+
ATPases. Under these conditions, store-operated Ca2+ influx
appeared inhibited but could be reactivated by decreasing [Ca2+]ER with the low affinity
Ca2+ chelator
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine. In contrast, [Ca2+]ER decreased much faster
during stimulation with carbachol. The larger ER release was associated
with a larger cytosolic Ca2+ response and, surprisingly,
with a shorter mitochondrial Ca2+ response. The reduced
mitochondrial signal was not associated with visible morphological
alterations of mitochondria or with disruption of the contacts between
mitochondria and the ER but correlated with a reduced mitochondrial
membrane potential. Altered ER and mitochondrial Ca2+
responses were also observed in cells expressing an
N-truncated calreticulin but not in cells overexpressing
calnexin, a P-domain containing chaperone, indicating that the effects
were mediated by the unique C-domain of calreticulin. In conclusion,
calreticulin overexpression increases Ca2+ fluxes across
the ER but decreases mitochondrial Ca2+ and membrane
potential. The increased Ca2+ turnover between the two
organelles might damage mitochondria, accounting for the increased
susceptibility of cells expressing high levels of calreticulin to
apoptotic stimuli.
 |
INTRODUCTION |
Ca2+ signals control key biological functions,
including fertilization, development, cardiac contraction, and
secretion of neurotransmitters and hormones (1). At the cellular level,
Ca2+ can be either a life and death signal, as changes in
cytosolic free Ca2+ concentration can control cell growth
and proliferation or induce apoptosis, the programmed cell death (2).
These diverging effects reflect the precise spatial and temporal
encoding of Ca2+ signals, which depends largely on the
controlled release of Ca2+ from intracellular
organelles. The main intracellular Ca2+ store is the
endoplasmic reticulum (ER),1
but mitochondria also take up and release Ca2+ very
efficiently and are often strategically located close to Ca2+ sources (see Refs. 3-6 and reviewed in Ref. 7). This
intimate connection allows mitochondria to shape Ca2+
signals (8) by modulating the release of Ca2+ from the ER
(9) and the influx of Ca2+ across the plasma membrane (10),
or by providing a local source of Ca2+ for ER refilling
(11). To achieve such precise control over Ca2+ fluxes, the
ER and mitochondria are equipped with a variety of Ca2+
transport and storage proteins and exert a tight control of the Ca2+ concentration within their lumen. Ca2+
fluxes across the ER membrane are stringently dependent on the free
Ca2+ concentration within the ER,
[Ca2+]ER, as Ca2+ allosterically
modulates the activity of the InsP3 receptor, the main
Ca2+-release channel of the ER. In addition, changes in
[Ca2+]ER regulate the Ca2+
permeability of store-operated channels (SOC) at the plasma membrane (12). The mechanism of this "capacitative" coupling is still elusive and has been proposed to involve the diffusion of a soluble messenger (13), direct interaction between InsP3 receptors
and SOC channels (14), or a secretion-like docking mechanism (15).
In addition to these Ca2+ signaling functions, the
Ca2+ concentration within the ER lumen and the
mitochondrial matrix also affects many functions of these organelles.
The activity of several ER resident chaperone proteins is modulated by
changes in [Ca2+]ER, which thereby indirectly
regulates the processing, sorting, and secretion of cargo proteins
(16). In mitochondria, Ca2+ directly controls the activity
of several dehydrogenases, thereby coupling the cell metabolism to the
Ca2+ signal (17, 18). The mitochondrial "decoding" of
Ca2+ signals allows cells to quickly respond to an
increased energy demand but can be turned into a death signal during
concomitant exposure to apoptotic stimuli (reviewed in Ref. 19). In the presence of ceramide, even physiological Ca2+ responses of
mitochondria to InsP3-generating agonists are sufficient to
induce apoptosis, possibly via Ca2+-dependent
opening of the permeability transition pore (20). The Ca2+
content of the ER also affects the cell sensitivity to apoptotic stimuli. A decreased [Ca2+]ER was observed in
cells overexpressing the antiapoptotic protein Bcl-2 (21, 22), and
a variety of conditions that decreased [Ca2+]ER has been shown to protect cells from
ceramide-induced cell death (23). The opposite effect was observed in
cells overexpressing the Ca2+-ATPases (SERCA2b) or the
ER-resident Ca2+-binding chaperone calreticulin, which
increased the Ca2+ content of the ER (23-25). Conversely,
cells lacking the calreticulin had a decreased ER Ca2+
content and were more resistant to apoptotic stimuli (26). Calreticulin-deficient cells, however, had normal
[Ca2+]ER levels, suggesting that the ability
of calreticulin to modulate the cell sensitivity to apoptotic stimuli
might be linked to changes in the total Ca2+ content of the
ER rather than to changes in [Ca2+]ER.
Calreticulin is a 46-kDa Ca2+-binding chaperone that
interacts in a Ca2+-dependent fashion with
several ER resident proteins, with unfolded glycoproteins, and with
Ca2+ transporters at the ER membrane (27, 28). Calreticulin
is composed of three structural and functional domains as follows: a
highly conserved N-terminal domain, involved in chaperone function and
in the interactions with other ER chaperones; a proline-rich P-domain,
which shares significant amino acid sequence identity with calnexin,
calmegin, and CALNUC and is involved in the chaperone function of
calreticulin; and a C-terminal domain that binds Ca2+ ions
with low affinity and high capacity (29). The Ca2+-binding
C-domain has been postulated to be the "Ca2+ sensor"
that regulates calreticulin interactions with other proteins (25, 29).
Because of the central role of the ER in Ca2+ signaling,
both the chaperoning functions of calreticulin as well as its
interactions with ER Ca2+ transporters can interfere with
Ca2+ signals. For example, calreticulin inhibits repetitive
Ca2+ waves by interacting selectively with distinct
isoforms of SERCA2 (30, 31). On the other hand, conflicting results
have been reported regarding the role of calreticulin in the modulation of store-operated Ca2+ influx (SOC). Stable up-regulation
of calreticulin in HEK-293 cells inhibits thapsigargin-induced
Ca2+ or Mn2+ influx (32), whereas transient
expression in RBL-1 cells only delays the activation of the
ICRAC current, to an extent that correlated with the extent
of store depletion (33). Similarly, in Xenopus oocytes
overexpressing calreticulin and stimulated with
InsP3-generating agonists, SOC inhibition correlated with increased [Ca2+]ER levels as expected from
the capacitative mechanism (34).
Because of the plethoric effects of the protein and the different
expression system used, the role of calreticulin in Ca2+
signaling remains controversial. To clarify the role of calreticulin in
Ca2+ homeostasis and in apoptosis, we generated cell lines
inducible for either the full-length calreticulin, an N-truncated
version lacking the chaperoning N-domain, or its chaperone homologue
calnexin. The effects of a controlled increase in protein levels on
cytosolic, ER, and mitochondrial Ca2+ signals were measured
using genetically encoded Ca2+-sensitive "cameleon"
indicators. The bright fluorescence and molecular targeting of the
probes allowed precise quantification of the changes in free
[Ca2+] occurring within the different cell compartments
at different times after the induction of protein expression.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Dulbecco's modified Eagle's culture medium,
fetal calf serum, penicillin, streptomycin, and geneticin were obtained
from Invitrogen. Thapsigargin, nigericin, monensin, ATP, and HEPES were
purchased from Sigma. Ionomycin was obtained from Calbiochem.
Hygromycin B, doxycycline, EGTA, and HEDTA were from Fluka
(Buchs, Switzerland). JC-1 and TMRM were from Molecular Probes
(Eugene, OR). Transfast transfection reagent was purchased from Promega
(Catalys AG, Switzerland). All other chemicals were of analytic grade
and were obtained from Fluka or Sigma. The "Ca2+
medium" contained 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM glucose, and 20 mM Hepes, pH 7.4. For the
"Ca2+-free medium" CaCl2 was omitted, and
0.5 mM EGTA was included. Drugs were dissolved in dimethyl
sulfoxide (Me2SO) or ethanol and diluted in the
recording medium on the day of use, at a final solvent concentration
<0.1%.
Constructs--
Plasmids YC2, YC2.1, and YC4ER were
kindly provided by Dr. R. Y. Tsien. Plasmid YC2mit and
YC4.1mit were generated as described previously (11).
cDNA encoding full-length or truncated (P + C-domain HA-tagged)
rabbit calreticulin and canine calnexin were subcloned into the pTRE
plasmid to generate pTRE-CRT, pTRE-P + C and pTRE-CNX expression
vectors, respectively. These vectors were used to generate Tet-On
inducible cell lines. Plasmid DNAs were purified using a Qiagen column
by the Maxi-prep purification protocol recommended by the manufacturer.
Generation of the Tet-On Cell Lines--
The Tet-On cell lines
were generated by co-transfecting pTRE-CRT, pTRE-P + C, or pTRE-CNX
with pTK-Hyg at a ratio 20:1 into HEK-293 cells (HeLa cells) by the
Ca2+-phosphate protocol. Transfected cells were selected
for growth in the presence of 200 µg of hygromycin B/ml of culture
medium. Single colonies of the hygromycin B-resistant cells were tested for doxycycline (Dox)-dependent expression of calreticulin,
P + C-domain, and calnexin by Western blotting with anti-calreticulin, anti-HA, and anti-calnexin antibodies. Three cell lines with the highest inducible expression of calreticulin, P + C-domain, and calnexin were selected for this study.
Cell Culture--
HEK-293 or Tet-On cell lines were grown in
Dulbecco's modified Eagle's medium containing 10% heat-inactivated
fetal calf serum, 2 mM L-glutamine, 50 units/ml
penicillin, 50 µg/ml streptomycin and were maintained in a humidified
incubator at 37 °C in the presence of 5% CO2, 95% air.
Cells (~200,000) were plated on 25-mm glass coverslips. With HEK-293
at 60% of confluency, the cells were transiently transfected with
cDNAs encoding the yellow cameleon probes. Cells were imaged 3-5
days after transfection. Stable HEK-293 transfectants were grown in the
presence of geneticin (100 µg/ml) for 3 weeks, and ~20 clones were
expanded for each condition and tested for expression of the probes. 2 µg of Dox/ml was added into the culture medium to induce expression
of calreticulin, its P + C-domain, or calnexin in Tet-On cell lines.
Immunoblotting and Immunocytochemistry--
Western blot
analysis with the use of goat anti-calreticulin, anti-HA, and rabbit
anti-calnexin antibodies was carried out as described (25). For
indirect immunofluorescence of calreticulin expressing HEK Tet-On cells
were plated on coverslips pretreated with polylysine and cultured in
the presence or absence of 2 µg of Dox/ml for 72 h. Cells were
washed 3 times with PBS, fixed with 3.7% paraformaldehyde for 20 min,
and permeabilized with 0.3% Triton X-100 for 20 min. Calreticulin was
detected by incubation with a goat anti-calreticulin antibody followed
by staining with a rabbit anti-goat antibody conjugated to Texas Red
(Jackson ImmunoResearch).
[Ca2+] Measurements--
Cells plated on 25-mm
coverslips were superfused at 37 °C in a thermostatic chamber
(Harvard Apparatus, Holliston, MA) equipped with gravity feed inlets
and vacuum outlet for solution changes. Dual-emission ratio imaging of
[Ca2+] with cameleon probes was performed as described
previously (11). Cameleon fluorescence from cells was imaged on a
Axiovert S100 TV using a 100×, 1.3 NA oil-immersion objective (Carl
Zeiss AG, Feldbach, Switzerland). Cells were excited by the 430 ± 10 nm line from a monochromator (DeltaRam, Photon Technology
International Inc., Monmouth Junction, NJ) through a 455DRLP dichroic
mirror. Fluorescence emission from the cameleons was imaged using a
cooled, 16-bits CCD back-illuminated frame transfer MicroMax camera
(Princeton Instruments, Roper Scientific, Trenton, NJ) at two emission
wavelengths, using a filter wheel (Ludl Electronic Products, Hawthorn,
NY) to alternately change the two emission filters (475DF15 and
535DF25, Omega Optical, Brattleboro, VT). Image acquisition and
analysis was performed with the Metamorph/Metafluor 4.1.2 software
(Universal Imaging, West Chester, PA). Changes in fluorescence ratio,
R = (fluorescence intensity at 535 nm
background intensity
at 535 nm)/(fluorescence intensity at 475 nm
background
intensity at 475 nm), were calibrated in [Ca2+] using
Equation 1,
|
(Eq. 1)
|
where Rmax and Rmin are the ratios
obtained, respectively, in the absence of Ca2+ and at
saturating Ca2+. K
is
the apparent dissociation constant, and n is the Hill
coefficient of the Ca2+ calibrations curves obtained
in situ for each cameleon.
For better three-dimensional rendering wide field or confocal image
stacks were deconvoluted after acquisition on a Silicon Graphics Octane
work station using the Huygens 2 software, and shadow projections were
constructed using the Imaris software (Bitplane AG, Zurich, Switzerland).
 |
RESULTS |
To generate cells inducible for calreticulin, we stably
transfected HEK-293 cells with a rabbit calreticulin cDNA construct driven by the tetracycline promoter (Tet-ON). The activation of calreticulin gene transcription by doxycycline (Dox), added to the
culture medium, was confirmed by immunoblotting with a goat polyclonal
CRT antibody (Fig. 1A).
Quantification of the immunoblot indicated that the cellular
calreticulin content increased by 2.5-fold within 24 h and
remained at this level for up to 5 days in culture. The induction was
specific for calreticulin, as addition of Dox had no effect on the
expression of other ER luminal chaperones such as ERp57 or Bip (not
shown). An immunostaining with a calreticulin-specific antibody
confirmed that protein expression was much stronger in Dox-induced
cells and still displayed the reticular pattern typical of the ER (Fig.
1B, left). No immunoreactivity was observed in the cytosol
or at the plasma membrane, confirming that, after induction,
calreticulin remained localized within the ER lumen. The ER structure
was not noticeably altered, because Dox induction did not affect the
intracellular distribution of the ER-targeted Ca2+
indicator YC4ER (Fig. 1B, right). This indicated
that the increase in calreticulin did not interfere with the import, ER
retention, or folding efficiency of the GFP-based indicator. Moreover,
the Ca2+ affinity of both the ER-targeted probe
YC4ER and of the cytosolic probe YC2, measured in
situ in cells permeabilized with ionomycin or digitonin, was not
affected by the increased expression of calreticulin (Fig.
1C). Thus, Dox induction increased the amount of
calreticulin within the ER lumen in a controlled manner, without interfering with the targeting specificity or Ca2+
dependence of the cameleon Ca2+ indicators.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Time course and specificity of
calreticulin induction by doxycycline. A, Western
blot of HEK-293 cells stably transfected with the Tet-ON CRT construct.
Cells were treated with 2 µM doxycyline for the indicated
times. B, effects of doxycycline induction on
calreticulin immunostaining and on YC4ER fluorescence.
Tet-ON cells were cultured for 3 days in the absence (top)
or presence (bottom) of 2 µM doxycycline. The
cells were then fixed and stained with a goat anti-CRT antibody and
observed by confocal microscopy using identical acquisition settings
(left). YC4ER fluorescence was assessed in live
cells by confocal microscopy (right). Images are shadow
projections of six adjacent, 400-nm wide z sections deconvoluted with
the iterative constrained Tikhonov-Miller restoration algorithm. The
induced calreticulin retained its reticular staining pattern and did
not affect the subcellular distribution of YC4ER.
cont, control. C, in situ
Ca2+ calibration curves of cells expressing
YC2cyt and YC4ER, cultured in the absence
(control, black circles) or presence of
doxycycline for 3 days (Dox, green circles). The
induction of calreticulin had no effect on the Ca2+
affinity of the probes. Size bar indicates 5 µm.
|
|
Effect of Calreticulin Induction on ER [Ca2+]
Homeostasis--
To assess whether the sustained increase in
calreticulin levels interfered with ER Ca2+ homeostasis, we
measured the changes in the free Ca2+ concentration within
the ER lumen, [Ca2+]ER, using the low
affinity ER-targeted ratiometric "cameleon" indicator
YC4ER (KD = 290 µM (11)).
YC4ER measurements revealed that the induction of
calreticulin markedly increased the resting
[Ca2+]ER levels (Fig.
2) with the basal
[Ca2+]ER values averaging 306 ± 31 µM in the absence and 595 ± 53 µM 72 h after Dox-dependent induction of calreticulin
expression. The increase could not be attributed to a specific ER
region, as higher [Ca2+]ER levels were
observed throughout the ER network in the ratio images (Fig.
2A). Thus, the 2.5-fold increase in calreticulin levels
caused, after 3 days of induction, a doubling in the free Ca2+ concentration within the ER lumen.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of calreticulin induction on ER
[Ca2+] homeostasis. A, YC4ER
emission ratio images (535/475 nm) of control and calreticulin-induced
cells, measured before and after stimulation with the SERCA inhibitor
thapsigargin (Tg). B,
[Ca2+]ER changes in control (cont)
and Dox-treated cells in response to Tg (1 µM) followed
by ionomycin (Iono) to maximally deplete ER stores. The
spatially averaged 535/475 ratio values were converted into
[Ca2+] using the calibration curve of Fig 1.
C, [Ca2+]ER changes induced
by 100 µM carbachol (CCh). Stimuli were
applied in the absence of external Ca2+, and
Ca2+ was re-added when indicated. Inset,
rate of ER Ca2+ pumping, measured at different
[Ca2+]ER values in control ( ) and
Dox-induced cells ( ). Data are pooled from 5 and 4 independent
experiments. D, average
[Ca2+]ER values measured in control and
Dox-treated cells under resting and depleted conditions. Data are
means ± S.E. (*, p < 0.01). The number of
experiments for each condition is indicated. Size bar
indicates 5 µm.
|
|
The doubling in resting [Ca2+]ER could
reflect either an increased Ca2+ pumping activity, or a
decrease in the passive Ca2+ permeability, or "leak" of
the ER. To distinguish between these possibilities, we studied the
effect of the SERCA inhibitor thapsigargin (Tg) on
calreticulin-dependent changes in free ER Ca2+.
Tg induced a slow decrease in [Ca2+]ER in
both control and calreticulin-induced cells (Fig. 2B). A
linear fit of the initial [Ca2+]ER decay
revealed that the kinetics of Ca2+ release were nearly
identical (
Ca2+ =
5.2 ± 0.3 versus
6.0 ± 0.3 µM/s), despite the higher
[Ca2+]ER in the calreticulin overexpressers.
Consequently, calreticulin-overexpressing cells retained a higher
[Ca2+]ER level throughout the course of Tg
stimulation. A further decline was observed upon addition of the
ionophore ionomycin (Fig. 2, B and D), indicating
that the ER Ca2+ store was not fully depleted by Tg. Thus,
a block of SERCA ATPases unmasked a nearly identical passive
Ca2+ permeability in the ER, regardless of the increase in
calreticulin levels.
In contrast, upon stimulation with the InsP3-generating
agonist carbachol (CCh), [Ca2+]ER decreased
much faster in CRT-induced cells, and similar depleted levels were
achieved within 100 s of agonist stimulation (Fig. 2, C
and D). The faster kinetics of Ca2+ release
(
Ca2+ =
4.5 ± 0.6 versus
11.4 ± 1.4 µM/min) suggested that calreticulin overexpression
increased the InsP3-stimulated Ca2+
permeability of the ER. Importantly, re-addition of Ca2+ to
the external medium resulted in a rapid increase of the
[Ca2+]ER in calreticulin-overexpressing cells
(Fig. 2C). The recovery rates were 1.9-fold higher in
calreticulin overexpressers than in control, non-induced cells, at any
given [Ca2+]ER (Fig. 2C, inset).
Because this assay measures the net flow of Ca2+ from the
external space to the ER, this indicates that both the influx of
Ca2+ across the plasma membrane and the ER Ca2+
pumping activity were increased in cells expressing high levels of
calreticulin. In the absence of agonist stimulation, the increased rates of ER refilling were not balanced by a parallel increase in the
endogenous ER Ca2+ permeability, resulting in higher
[Ca2+]ER levels at rest. However, induction
of calreticulin expression markedly increased the agonist-induced ER
Ca2+ permeability, and therefore, upon stimulation, more
Ca2+ was released from the ER lumen.
Effect of CRT Induction on Cytosolic Ca2+
Signals--
To assess how these changes in ER luminal
Ca2+ homeostasis influenced Ca2+ signals in the
cytosol, we monitored changes in cytoplasmic Ca2+,
[Ca2+]cyt, with the cytosolic YC2 probe
(KD = 1.24 µM). Ca2+
release from ER stores was measured in the absence of external Ca2+, and Ca2+ influx was subsequently measured
by re-adding Ca2+ to the external medium. Fig.
3 shows that both CCh and Tg elicited a
much larger increase in [Ca2+]cyt in
calreticulin overexpressing cells, indicating that substantially more
Ca2+ was released from the intracellular Ca2+
stores. Compared with previous studies using fura-2 (32), the differences between control and calreticulin overexpresser cells were
striking, reflecting the better adequacy of the YC2 probe to quantify
[Ca2+]cyt changes in the micromolar range.
Subsequent addition of Ca2+ to assess the activity of
store-operated Ca2+ channels at the plasma membrane
revealed that, as previously reported (32), Ca2+ influx was
severely blunted in Tg-stimulated calreticulin-overexpressing cells
(Fig. 3). This decreased influx correlated well with the increased
[Ca2+]ER levels measured with
YC4ER (Fig. 2) and indicated that, consistent with the
capacitative hypothesis, the activity of SOC channels is determined by
changes in [Ca2+]ER levels. Accordingly,
Ca2+ influx was similar in control and Dox-induced cells
stimulated with CCh, which had comparable
[Ca2+]ER levels (Figs. 2 and 3). However, in
this case the activity of SOC channels could not be readily inferred
from the changes in [Ca2+]cyt, because of the
concomitant ER Ca2+ pumping activity. Although
Ca2+ re-addition produced similar
[Ca2+]cyt changes, larger
[Ca2+]ER increases were observed in
calreticulin-overexpressing cells, indicating that substantially
more Ca2+ was taken up by the ER (Fig.
2A). This suggested that the net flux of Ca2+
ions across the plasma membrane was, in fact, larger in
calreticulin-induced cells but that the Ca2+ entering the
cell was rapidly taken up by the ER. Thus, the increased [Ca2+]ER levels observed in the presence of
Tg correlated with decreased SOC activity. In contrast, SOC activity
was high in calreticulin overexpresser cells stimulated with CCh but
did not translate into a larger cytosolic Ca2+ signal
because of the high concomitant ER Ca2+ pumping
activity.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of calreticulin induction on cytosolic
Ca2+ signals. A,
[Ca2+]cyt changes induced by Tg. Cells were
stimulated in the absence of external Ca2+, which was
re-added when indicated. B, average
[Ca2+]cyt responses elicited by Tg in control
(cont) and calreticulin-induced cells. C,
[Ca2+]cyt responses elicited by CCh.
D, average [Ca2+]cyt
responses measured with CCh. Data are mean ± S.E. of the
indicated number of experiment (*, p < 0.02; **,
p < 0.0001).
|
|
Time Course of the CRT Effects on ER and Cytosolic
[Ca2+]--
To better assess the effects of high
expression of calreticulin on Ca2+ handling, we measured
the [Ca2+]ER and
[Ca2+]cyt responses at different times
following the induction of protein expression. Fig.
4A shows that the resting
[Ca2+]ER levels were increased 24 h
after Dox-dependent induction of calreticulin expression
and remained elevated thereafter. In contrast, Ca2+ influx,
taken as the peak [Ca2+]cyt upon
Ca2+ re-addition to Tg-treated cells, was inhibited only 3 days after the induction with Dox (Fig. 4B, circles). The
amount of releasable Ca2+ followed a similar delayed time
course; the peak of Tg-induced [Ca2+]cyt
release was only marginally increased 24 h post-induction and
became significantly increased only 2 or 3 days after Dox induction of
calreticulin expression (Fig. 4B, squares). The strong correlation between SOC activation and the total stored
Ca2+ likely reflected the higher residual
[Ca2+]ER levels achieved at the end of the Tg
stimulation in calreticulin-overexpressing cells. Although an ~5-min
stimulation with Tg is routinely used to deplete Ca2+
stores, YC4ER measurements indicated that
[Ca2+]ER did not reach fully depleted levels
within the first 5 min in cells induced to express calreticulin for 3 days (Fig. 2). Thus, induction of calreticulin expression had two
temporally distinct effects on Ca2+ homeostasis as follows:
acute induction caused an immediate increase in
[Ca2+]ER, whereas more sustained expression
of high levels of calreticulin was required to increase the total
amount of stored Ca2+ and to inhibit store-operated
Ca2+ influx.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Time course of calreticulin effects on ER and
cytosolic [Ca2+]. A,
[Ca2+]cyt responses measured at different
times after Dox induction. B, the average
[Ca2+]cyt responses elicited by Tg in
Ca2+-free medium (release, squares) or during
subsequent readdition of Ca2+ (influx, circles)
are plotted against the duration of calreticulin induction.
C, corresponding [Ca2+]ER
levels measured at different times during Dox induction. Data are
mean ± S.E. (*, p < 0.02; **, p < 0.001).
|
|
To show that the [Ca2+]ER levels were indeed
the prime determinant of SOC activity, we acutely modulated
[Ca2+]ER using the low affinity
Ca2+ chelator
N,N,N',N'-tetrakis(2-pyridylmethyl)-ethylenediamine (TPEN). This cell membrane-permeant Ca2+ chelator has a
KD that matches the free Ca2+ levels in
the ER lumen, providing an excellent tool to clamp [Ca2+]ER without affecting the
[Ca2+]cyt responses (35). Fig.
5 shows that addition of TPEN produced a
rapid decrease in [Ca2+]ER but had only minor
effect on [Ca2+]cyt. The effects of TPEN were
reversible (not shown). The chelator did not prevent the
[Ca2+]ER changes induced by Tg. Therefore, it
was possible to artificially impose normal resting and depleted
[Ca2+]ER levels in
calreticulin-overexpressing cells (Fig. 5A). Cytosolic Ca2+ measurements revealed that a robust Ca2+
influx could be elicited with Tg in the presence of the ER luminal Ca2+ chelator, as expected from the capacitative mechanism
(Fig. 5B). This indicates that SOC channels were fully
functional in calreticulin overexpresser cells when
[Ca2+]ER was artificially clamped to the
level found in non-induced cells. Therefore, the high expression of
calreticulin had no effect per se on the activity of SOC
channels, which is determined primarily by the
[Ca2+]ER level in the ER lumen.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of TPEN on ER and cytosolic
[Ca2+]. A, effect of the
cell-permeant low affinity Ca2+ chelator TPEN on
[Ca2+]ER, measured in the absence of external
Ca2+ in Dox-induced cells. Iono, ionomycin.
B, averaged [Ca 2+]ER levels
measured before and after the addition of TPEN, which reduced the free
ER Ca2+ by 2.2 times. C, effect of TPEN on
the Tg-induced [Ca2+]cyt responses.
D, averaged [Ca2+]cyt
responses in control cells and in calreticulin-induced cells treated
with TPEN. Data are mean ± S.E. (* p < 0.05).
|
|
Effect of Calreticulin Induction on Mitochondrial Ca2+
Signals--
In addition to communicating with the plasma membrane,
the ER is also involved in a cross-talk with mitochondria, which are strategically located close to the sites of Ca2+ release
and can capture part of the Ca2+ released by the ER (6). To
assess whether the increased [Ca2+]ER levels
and InsP3-induced ER permeability also affected
mitochondria, we measured Ca2+ changes within the
mitochondrial matrix, [Ca2+]mit. Two
mitochondrial probes of different affinities were used as follows: the
high affinity YC2mit probe (KD = 1.24 µM), to allow accurate measurements within the low
micromolar range, and the low affinity YC4.1mit probe
(KD = 105 µM), to better resolve the
high levels achieved during peak [Ca2+]mit
responses (11). The basal [Ca2+]mit levels
reported by the YC2mit probe were not affected by the
induction of calreticulin. Surprisingly, however, YC4.1mit measurement revealed that the [Ca2+]mit
responses were blunted in calreticulin-induced cells (Fig. 6A). The peak
[Ca2+]mit levels measured with
YC4.1mit were close to 100 µM, consistent with earlier findings in chromaffin and HeLa cells (11, 36) and were
only slightly reduced in calreticulin cells (120 ± 16 (n = 10) versus 77 ± 12 µM (n = 9), p = 0.05).
However, a marked difference in the decay kinetics of the
[Ca2+]mit signal was observed, as
[Ca2+]mit returned much faster to basal
levels despite the continuous presence of the
InsP3-generating agonist (Fig. 6B). This
suggested that mitochondria were still able to take up the
Ca2+ released by the ER but that Ca2+ extrusion
from mitochondria was facilitated. As a result, the average
[Ca2+]mit level measured during CCh
application was significantly reduced in calreticulin-induced cells
(Fig. 6B). This finding was unexpected, as calreticulin
induction increased both the amount of releasable Ca2+, the
driving force for ER-to-cytosol Ca2+ release, and the
InsP3-induced Ca2+ permeability of the ER
(Figs. 2 and 3). The shorter duration of the
[Ca2+]mit signal suggested that the ability
of mitochondria to retain Ca2+ loads was impaired.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of calreticulin induction on
mitochondrial Ca2+ signals. A,
[Ca2+]mit changes measured with the low
affinity YC4mit probe, whose KD matches
the peak [Ca2+]mit values. B,
mean [Ca2+]mit levels recorded during the
time of CCh application (~120 s). Data are mean ± S.E. (*
p < 0.01). cont, control.
|
|
Effects of Calreticulin on Mitochondria Morphology and Membrane
Potential--
The abnormal mitochondrial response of calreticulin
cells suggested that calreticulin induction might cause structural or functional damages to mitochondria. Because mitochondria are tightly coupled to Ca2+ release sites at the ER membrane (6, 37),
subtle change in the architecture of the mitochondrial network might be
sufficient to cause dramatic effects on
[Ca2+]mit signals. On the other hand, changes
in mitochondrial membrane potential, 
m, which determines
the driving force for Ca2+, also directly impact on
[Ca2+]mit. To distinguish between these two
possibilities, we measured 
m and assessed the morphology
of mitochondria as well as their interactions with the ER. To assess
the morphology of mitochondria without relying on the extent of their
negative membrane potential, we used the genetically targeted indicator
DsRedmit. Fig. 7A
shows that the staining pattern of DsRedmit was not
markedly altered in calreticulin-induced cells. Upon Dox induction,
mitochondria retained their "worm-like" appearance and did not
appear swollen or condensed (Fig. 7A). Although a variety of
mitochondria morphologies was observed both in control and Dox-induced
cells, no systematic alterations could be observed in association with
the induction of calreticulin expression. More importantly, the overlap
between the mitochondrial and the ER signal was similar in control and calreticulin cells, as assessed by co-labeling cells with
YC4ER and Mitotracker Red (Fig. 7B). In both
conditions, mitochondria appeared embedded into the ER, suggesting that
the induction of calreticulin did not disrupt the interactions between
the ER and mitochondria. Thus, although the resolution of the confocal
microscope did not allow us to resolve the contact points between the
ER and mitochondria, the structural integrity as well as the
relationship between the two organelles appeared to be preserved.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of calreticulin induction on
mitochondria morphology and membrane potential. A,
staining patterns of a mitochondrial targeted DsRedmit
(kindly provided by Dr. T. Pozzan, Padua). Images are shadow
projections of z stacks of confocal images deconvoluted and processed
using the Huygens and Imaris software. B,
YC4ER-expressing cells were co-labeled with Mitotracker Red
to assess the interaction between the ER and mitochondria. Images were
acquired and processed as in A. C, TMRM
(left) and JC-1 (right) measurements of the
mitochondrial membrane potential.  m is expressed as the
ratio of the mitochondrial over cytosolic TMRM fluorescence
(left) or as the percentage of the JC-1 stained area
containing red fluorescent aggregates (right). Data are
mean ± S.E. (*, p < 0.005). Size bar
indicates 5 µm.
|
|
We next measured the mitochondrial membrane potential, 
m,
using the rhodamine-based dye TMRM, which accumulates into polarized
mitochondria. The 
m-driven accumulation of TMRM into
mitochondria was quantified as the ratio of the mitochondrial over
cytosolic fluorescence intensity (38). The TMRM ratio was significantly
lower in Dox-induced cells (Fig. 7C, left panel), indicating that 
m was reduced by long term overexpression of calreticulin. The decrease in 
m was not due to TMRM photoactivation and subsequent local generation of reactive oxygen species (ROS) (39), as determined by time lapse imaging. The TMRM ratio
was already lower in Dox-induced cells illuminated for the first time,
and did not change subsequently over the 20 min recording period (data
not shown). The decrease in 
m was confirmed by
measurements with JC-1, a potentiometric dye that forms red-emitting
aggregates at negative 
m (38). As shown in Fig.
7C, the proportion of red-emitting JC-1 aggregates was
markedly reduced in Dox-induced cells (Fig. 7C, right
panel). Thus, the abnormal [Ca2+]mit
response of calreticulin-overexpressing cells correlated with a
decreased mitochondrial membrane potential, with no visible alteration
in the mitochondrial architecture.
Role of the Ca2+ Binding C-domain of
Calreticulin--
Calreticulin is a multifunctional protein, and
different regions of the protein perform different functions (29). For
example, the N- + P-domains of calreticulin are involved in chaperone
function, whereas the C-domain of the proteins plays a role of
Ca2+ storage and "Ca2+ sensing" in the ER
lumen (29). To identify the region of calreticulin involved in
Ca2+ and organelle homeostasis, we generated Tet-ON cells
inducible for a truncated calreticulin, encoding the P + C-domain,
which contains a critical Ca2+-binding region in
calreticulin. Dox-induced expression of the P + C-domain was at similar
levels as the wild-type protein, as assessed by immunofluorescence and
Western blotting (not shown). Fig. 8
shows that the P + C-domain mimicked the effects of the full-length
calreticulin. The Dox-induced cells overexpressing the P + C-domain had
a higher resting [Ca2+]ER, increased residual
[Ca2+]ER levels after Tg stimulation, and a
lower [Ca2+]mit signal (Fig. 8, C
and D). In addition the reduction of TMRM fluorescence was
also measured in P + C-induced cells (Fig. 8E). This
suggested that the Ca2+ sensing and Ca2+
storage C-domain of calreticulin was responsible for the deleterious effects. Despite repeated attempts we were unable to generate cells
overexpressing either the N- or C-domain alone. However, it is unlikely
that the chaperone P-domains of calreticulin play a role because
Dox-inducible expression of ER chaperone calnexin, which contains a
similar P-domain, did not reproduce the effect on
[Ca2+]ER (Fig. 8B). In summary,
these data suggest that the low affinity, high capacity
Ca2+-binding C-domain, rather that the chaperone
interacting regions of calreticulin, mediate the effects on
[Ca2+]ER leading to modulation of SOC and
mitochondrial Ca2+ homeostasis.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of calreticulin domains.
A, schematic representation of calreticulin and
calnexin domains (27). B, average
[Ca2+]ER values in cells induced to express
the P-domain containing chaperone calnexin.
[Ca2+]ER was measured in the absence of
external Ca2+, before and 5 min after application of Tg.
C, [Ca2+]ER values in cells
induced to express the P + C-domain of calreticulin (P + C-domain).
D, [Ca2+]mit responses
measured with the YC4.1mit probe in the P + C-domain Tet-ON
cells. The average values recorded during the CCh application are
shown. E, TMRM fluorescence intensity ratio between
mitochondria and the cytosol, measured in control and P + C-domain-induced cells. Data are mean ± S.E. (*,
p < 0.05; **, p < 0.005).
|
|
 |
DISCUSSION |
In this study we report that differential expression of
calreticulin in the lumen of ER affects the Ca2+
homeostasis of distinct cellular compartments. Altered Ca2+
signals were observed in the ER, in the cytosol, at the plasma membrane, and in the mitochondria. The most predominant effects of
increased expression of calreticulin occurred at the level of ER, where
the protein resides. Consistent with all previous studies (23, 32, 34,
40), we found that calreticulin overexpression increased the total
amount of Ca2+ stored in the ER, an effect that occurred
within days after the induction of protein expression. In addition, we
found that the increased expression of calreticulin has a significant
effect on the free intraluminal ER Ca2+. The free
Ca2+ concentration within the ER lumen,
[Ca2+]ER, nearly doubled within 24 h of
induction of calreticulin expression and remained at these elevated
levels for several days. This is in contrast to an earlier report
wherein oocyte [Ca2+]ER levels were either
not affected (34) or slightly decreased (31) when calreticulin was
overexpressed. Although different expression systems were used, these
diverging effects of calreticulin relate to cellular systems expressing
the same SERCA isoform. In this study, increased
[Ca2+]ER levels and Ca2+ pumping
activity were observed in calreticulin-overexpressing HEK-293 cells,
which contain predominantly the SERCA2b isoform (Fig. 2). In contrast,
in oocytes co-injected with calreticulin and the SERCA2b expression
vectors, decreased [Ca2+]ER and
Ca2+ pumping activities were observed (31). In both cases,
Ca2+ pumping activity directly correlated with the
[Ca2+]ER levels, consistent with recent
results (24) showing that overexpression of SERCA2b increases
[Ca2+]ER by 25% in Chinese hamster ovary
cells. In the present study, calreticulin levels were increased by
2.5-fold, Ca2+ pumping activity by 1.9-fold, and
[Ca2+]ER by 1.8-fold. This excellent
correlation reflected the imbalance between the increased
Ca2+ pumping activity and the endogenous Ca2+
permeability of the ER, which was unaffected by calreticulin.
The increased Ca2+ pumping activity, however, was not
mediated by SERCA isoforms, as inferred from the effects of
thapsigargin. Thapsigargin, added at concentrations that fully inhibit
SERCA, unmasked a nearly identical passive ER Ca2+
permeability in control and calreticulin overexpressers (Fig. 2B). Because at steady state the Ca2+ pumping
activity is equal to the ER Ca2+ leak, this indicates that,
under resting conditions, the activity of SERCA was not altered in the
calreticulin overexpressers. Thus, thapsigargin-insensitive
Ca2+ pumps mediate the increased ER refilling observed
during Ca2+ re-addition to Ca2+-depleted cells
(Fig. 2C). A likely candidate is the Pmr1 family of
Ca2+ transport ATPases, which has been shown recently (41)
to be expressed and functional in mammalian cell lines. The
thapsigargin-insensitive Pmr1 pump is localized mainly to the Golgi
complex, but a substantial fraction is present and functional in the
ER. The Pmr1 store had a reduced Ca2+ leak and weak
InsP3 responses, and COS-7 cells overexpressing the Pmr1
pump had delayed Ca2+ influx (42). It is tempting to
speculate that calreticulin, by interacting with the Golgi-targeted
Pmr1 pump, might promote its retention in the ER, thereby accounting
for the increased Ca2+ pumping activity observed in
calreticulin overexpressers. In any case, the existing evidence
strongly suggests that calreticulin interacts differentially with
distinct Ca2+ pump isoforms and modulates the rates of
Ca2+ uptake into the ER, thereby directly altering
[Ca2+]ER. The physiological relevance of
these interactions is not clear, but a decreased
[Ca2+]ER has been shown to activate the
transcription of the calreticulin gene (43). Therefore, an increase in
calreticulin level in the ER would rapidly restore normal
[Ca2+]ER levels, thereby abrogating its
transcriptional activation. Consistent with such a feedback mechanism,
the [Ca2+]ER increase was the first
perturbation observed upon the induction of calreticulin.
In addition to increasing the total and free Ca2+ of the
ER, calreticulin also increased the rates of agonist-induced
Ca2+ release. Increased release was observed over a wide
range of [Ca2+]ER, indicating that it did not
simply reflect the increased driving force for Ca2+ but
increased fluxes through InsP3-gated channels. This was
unexpected, because it was reported recently (24) that the rates of
ATP-induced Ca2+ release were decreased in cells with
increased [Ca2+]ER due to overexpression of
SERCA. This effect was attributed to the
Ca2+-dependent inhibition of
InsP3-gated channels. Because in our calreticulin-induced
cells the InsP3 channels were also exposed to higher
amounts of Ca2+ ions, both on the ER and on the cytosolic
side, the increased release might reflect a direct action of
calreticulin on InsP3-gated Ca2+ channels.
Because of the increased ER Ca2+ load and the increased
driving force for Ca2+, more Ca2+ was released
into the cytosol during stimulation with agonists and/or thapsigargin,
and store-operated Ca2+ influx was reduced when measured
with the Ca2+ re-addition protocol (Fig. 3). However,
analysis of the cytosolic and ER responses at different times after
induction indicated that calreticulin levels had no direct effects on
store-operated Ca2+ influx. Decreased SOC activity was only
observed in cells induced to express CRT for 3 days and correlated with
an increase in total stored Ca2+, rather than with the
resting [Ca2+]ER levels (Fig. 4). In previous
studies, decreased Ca2+ influx was observed in stable
calreticulin overexpressers (32) but not in cells transiently
transfected with calreticulin (33). Our observations reconcile these
apparently discrepant findings and caution against the Ca2+
re-addition protocol to assess store-operated Ca2+ influx,
because 1) the degree of store depletion cannot be readily estimated
from the cytosolic Ca2+ responses, and 2) the concomitant
activity of SERCA greatly affects the dynamics of the
[Ca2+]cyt signal, precluding accurate
estimates of the influx component.
The effects of calreticulin extended beyond the ER and affected another
organelle, the mitochondria. However, the larger release of
Ca2+ from the ER was not associated with an equally larger
Ca2+ accumulation in mitochondria but with a reduced signal
as [Ca2+]mit rapidly returned to basal levels
despite the presence of InsP3-generating agonists (Fig. 6).
The abnormal [Ca2+]mit response did not
reflect structural damage, because the shapes and numbers of
mitochondria as well as their relationship to the ER appeared normal by
confocal microscopy, but was associated with a mitochondrial
depolarization (Fig. 7). The depolarization, by reducing the driving
force for Ca2+, is expected to reduce mitochondrial
Ca2+ uptake and might thus account for the blunted
[Ca2+]mit response. In addition, the activity
of the mitochondrial Ca2+ uniporter might be further
inhibited by the high Ca2+ concentrations found at the
ER/mitochondria microdomain. Prolonged exposures to high
Ca2+ concentrations might desensitize the uniporter, as
exposures to low Ca2+ concentrations are needed to reset
the uniporter into rapid uptake mode, its most efficient mode of
Ca2+ uptake (44). Furthermore, the mitochondria
Ca2+ uptake sites have been shown to be already close to
saturation during physiological stimulations (6, 37), suggesting that exposure of mitochondria to higher Ca2+ microdomains might
not translate into higher [Ca2+]mit responses.
This mechanism might account for the preserved amplitude of the peak
[Ca2+]mit response in calreticulin
overexpressers, despite the larger release of Ca2+ from the
ER. The increased ER Ca2+ pumping activity of calreticulin
overexpressers (Fig. 2) might further contribute to the abnormal
[Ca2+]mit response, by dissipating more
efficiently the local Ca2+ microdomain surrounding
mitochondria. Because of its slow kinetics, the increased ER
Ca2+ pumping is not likely to affect the peak
[Ca2+]mit but might contribute to the faster
decay of the [Ca2+]mit response by removing
more efficiently the Ca2+ released by mitochondria (11).
Thus, several mechanisms might account for the abnormal
[Ca2+]mit response observed in
calreticulin-induced cells, including a decrease in mitochondrial
membrane potential, an inhibition of the Ca2+ uniporter,
together with an increased Ca2+ uptake and release from the
ER. A causal link between the increased ER Ca2+ release and
mitochondrial depolarization might even be postulated, as mitochondria
are likely to be damaged by the chronic exposure to high
Ca2+ concentrations.
These perturbations of Ca2+ homeostasis are unlikely due to
the chaperone function of calreticulin, as impaired ER and
mitochondrial Ca2+ responses were observed in cells induced
to express a truncated calreticulin lacking the chaperone N-domain of
the protein (Fig. 8). Most importantly, the overexpression of calnexin,
an ER chaperone similar to calreticulin and containing a chaperoning
P-domain, did not affect cytosolic or ER Ca2+ homeostasis.
This indicates that the effects do not require either the N- or the
P-domain but are mediated by the unique C-domain of calreticulin. Thus,
alterations in Ca2+ sensing, rather that in chaperone
activity, are responsible for the increased Ca2+ pumping
and release activity, which lead to higher Ca2+ turnover
between the ER and mitochondria. These findings have important
physiological implications because different levels of calreticulin are
expressed in different tissues (28). Furthermore, expression of the
protein is up-regulated under the conditions of stress and starvation
(28). In the immune system, the CRT gene is activated in
stimulated cytotoxic T-cells (45) where it may play a role in a
Ca2+-dependent signaling and/or cytotoxic
T-cell killing. In many cancer cells, including prostate cancer,
calreticulin expression is increased or up-regulated by different
steroids (46, 47). Expression of calreticulin is also differentially
regulated during development (48). Because the Ca2+ signals
of multiple cellular compartments are differentially modulated by
calreticulin, changes in calreticulin expression levels might define
specific patterns of cellular Ca2+ responses in these cell
types. By allowing the ER to take up, store, and release more
Ca2+, an increase in calreticulin might "arm" the
cellular Ca2+ signaling machinery, thereby allowing
previously "silent" cells to generate Ca2+ signals. In
the long run, however, an increase in calreticulin appears to be
deleterious for the cell, despite the reduction in Ca2+
influx that compensates for the increased Ca2+ release from
the ER. The high Ca2+ microdomains around mitochondria,
which might in the short term increase mitochondrial metabolism, might
in the long run damage and depolarize mitochondria. This defective
signaling might account for the increased susceptibility of cells
expressing high levels of calreticulin to apoptotic stimuli.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Tullio Pozzan, Padua, for
the kind gift of the mitochondria-targeted red fluorescent protein, and
Drs. R. Y. Tsien and A. Miyawaki for providing the yellow cameleon constructs.
 |
FOOTNOTES |
*
This work was supported by NSF Grants 31-46859.96 and
31-56802.99 from the Swiss National Science Foundation, the Canadian Institutes of Health Research, and the Heart and Stroke
Foundation of Alberta.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Canadian Institutes of Health Research Senior Investigator and
an Alberta Heritage Foundation for Medical Research Medical Scientist.
Fellow of the Dr. Max Cloetta Foundation. To whom
correspondence should be addressed: Dept. of Physiology, University of
Geneva Medical Center 1, Michel-Servet CH-1211 Geneva 4, Switzerland. Tel.: 4122-702-5399; Fax: 4122-702-5402; E-mail:
Nicolas.Demaurex@medecine.unige.ch.
Published, JBC Papers in Press, September 24, 2002, DOI 10.1074/jbc.M202395200
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic
reticulum;
Dox, doxycycline;
InsP3, inositol
1,4,5-trisphosphate;
SOC, store-operated Ca2+ influx;
SERCA, sarco(endo)plasmic reticulum Ca2+ transport ATPase,
[Ca2+]cyt,
[Ca2+]ER, and
[Ca2+]mit, cytosolic, ER, and
mitochondria-free Ca2+ concentration, respectively;
CCh, carbachol;
YC, yellow cameleon;
DsRed, Red fluorescent protein from
Discosoma sp.;
TPEN, N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine;
Tg, thapsigargin;
Tet, tetracycline;
HA, hemagglutinin;
TMRM, tetramethylrhodamine methyl ester;
CRT, calreticulin;
HEDTA, N-(2-hydroxyethyl)ethylenediamine-N,N',N'-triacetic
acid.
 |
REFERENCES |
| 1.
|
Berridge, M. J.,
Lipp, P.,
and Bootman, M. D.
(2000)
Nat. Rev. Mol. Cell. Biol.
1,
11-21[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Berridge, M. J.,
Bootman, M. D.,
and Lipp, P.
(1998)
Nature
395,
645-648[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Rizzuto, R.,
Simpson, A. W.,
Brini, M.,
and Pozzan, T.
(1992)
Nature
358,
325-327[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Rizzuto, R.,
Brini, M.,
Murgia, M.,
and Pozzan, T.
(1993)
Science
262,
744-747[Abstract/Free Full Text]
|
| 5.
|
Babcock, D. F.,
Herrington, J.,
Goodwin, P. C.,
Park, Y. B.,
and Hille, B.
(1997)
J. Cell Biol.
136,
833-844[Abstract/Free Full Text]
|
| 6.
|
Rizzuto, R.,
Pinton, P.,
Carrington, W.,
Fay, F. S.,
Fogarty, K. E.,
Lifshitz, L. M.,
Tuft, R. A.,
and Pozzan, T.
(1998)
Science
280,
1763-1766[Abstract/Free Full Text]
|
| 7.
|
Rizzuto, R.,
Bernardi, P.,
and Pozzan, T.
(2000)
J. Physiol. (Lond.)
529,
37-47[Abstract/Free Full Text]
|
| 8.
|
Jouaville, L. S.,
Ichas, F.,
Holmuhamedov, E. L.,
Camacho, P.,
and Lechleiter, J. D.
(1995)
Nature
377,
438-441[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Hajnoczky, G.,
Hager, R.,
and Thomas, A. P.
(1999)
J. Biol. Chem.
274,
14157-14162[Abstract/Free Full Text]
|
| 10.
|
Hoth, M.,
Fanger, C. M.,
and Lewis, R. S.
(1997)
J. Cell Biol.
137,
633-648[Abstract/Free Full Text]
|
| 11.
|
Arnaudeau, S.,
Kelley, W. L.,
Walsh, J. V., Jr.,
and Demaurex, N.
(2001)
J. Biol. Chem.
276,
29430-29439[Abstract/Free Full Text]
|
| 12.
|
Putney, J. W., Jr.,
and McKay, R. R.
(1999)
Bioessays
21,
38-46[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Randriamampita, C.,
and Tsien, R. Y.
(1993)
Nature
364,
809-814[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Berridge, M. J.
(1995)
Biochem. J.
312,
1-11[Medline]
[Order article via Infotrieve]
|
| 15.
|
Patterson, R. L.,
van Rossum, D. B.,
and Gill, D. L.
(1999)
Cell
98,
487-499[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Corbett, E. F.,
Oikawa, K.,
Francois, P.,
Tessier, D. C.,
Kay, C.,
Bergeron, J. J.,
Thomas, D. Y.,
Krause, K. H.,
and Michalak, M.
(1999)
J. Biol. Chem.
274,
6203-6211[Abstract/Free Full Text]
|
| 17.
|
Hajnoczky, G.,
Robb-Gaspers, L. D.,
Seitz, M. B.,
and Thomas, A. P.
(1995)
Cell
82,
415-424[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Robb-Gaspers, L. D.,
Burnett, P.,
Rutter, G. A.,
Denton, R. M.,
Rizzuto, R.,
and Thomas, A. P.
(1998)
EMBO J.
17,
4987-5000[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Duchen, M. R.
(1999)
J. Physiol. (Lond.)
516,
1-17[Abstract/Free Full Text]
|
| 20.
|
Szalai, G.,
Krishnamurthy, R.,
and Hajnoczky, G.
(1999)
EMBO J.
18,
6349-6361[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Foyouzi-Youssefi, R.,
Arnaudeau, S.,
Borner, C.,
Kelley, W. L.,
Tschopp, J.,
Lew, D. P.,
Demaurex, N.,
and Krause, K. H.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
5723-5728[Abstract/Free Full Text]
|
| 22.
|
Pinton, P.,
Ferrari, D.,
Magalhaes, P.,
Schulze-Osthoff, K., Di,
Virgilio, F.,
Pozzan, T.,
and Rizzuto, R.
(2000)
J. Cell Biol.
148,
857-862[Abstract/Free Full Text]
|
| 23.
|
Pinton, P.,
Ferrari, D.,
Rapizzi, E., Di,
Virgilio, F. D.,
Pozzan, T.,
and Rizzuto, R.
(2001)
EMBO J.
20,
2690-2701[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Brini, M.,
Bano, D.,
Manni, S.,
Rizzuto, R.,
and Carafoli, E.
(2000)
EMBO J.
19,
4926-4935[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Nakamura, K.,
Bossy-Wetzel, E.,
Burns, K.,
Fadel, M. P.,
Lozyk, M.,
Goping, I. S.,
Opas, M.,
Bleackley, R. C.,
Green, D. R.,
and Michalak, M.
(2000)
J. Cell Biol.
150,
731-740[Abstract/Free Full Text]
|
| 26.
|
Nakamura, K.,
Zuppini, A.,
Arnaudeau, S.,
Lynch, J.,
Ahsan, I.,
Krause, R.,
Papp, S., De,
Smedt, H.,
Parys, J. B.,
Muller-Esterl, W.,
Lew, D. P.,
Krause, K. H.,
Demaurex, N.,
Opas, M.,
and Michalak, M.
(2001)
J. Cell Biol.
154,
961-972[Abstract/Free Full Text]
|
| 27.
|
Krause, K. H.,
and Michalak, M.
(1997)
Cell
88,
439-443[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Michalak, M.,
Corbett, E. F.,
Mesaeli, N.,
Nakamura, K.,
and Opas, M.
(1999)
Biochem. J.
344,
281-292[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Corbett, E. F.,
and Michalak, M.
(2000)
Trends Biochem. Sci.
25,
307-311[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Camacho, P.,
and Lechleiter, J. D.
(1995)
Cell
82,
765-771[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
John, L. M.,
Lechleiter, J. D.,
and Camacho, P.
(1998)
J. Cell Biol.
142,
963-973[Abstract/Free Full Text]
|
| 32.
|
Mery, L.,
Mesaeli, N.,
Michalak, M.,
Opas, M.,
Lew, D. P.,
and Krause, K. H.
(1996)
J. Biol. Chem.
271,
9332-9339[Abstract/Free Full Text]
|
| 33.
|
Fasolato, C.,
Pizzo, P.,
and Pozzan, T.
(1998)
Mol. Biol. Cell
9,
1513-1522[Abstract/Free Full Text]
|
| 34.
|
Xu, W.,
Longo, F. J.,
Wintermantel, M. R.,
Jiang, X.,
Clark, R. A.,
and DeLisle, S.
(2000)
J. Biol. Chem.
275,
36676-36682< |